Skip to Main Content

Paper Details

ARID1A mutation associated with recurrence and shorter progression-free survival in atypical meningiomas.
J Cancer Res Clin Oncol
4
2023
ARID1A, WHO grade II meningiomas, atypical, atypical meningiomas, chromatin remodeling gene, meningiomas, patients, primary tumors, recurrent, recurrent tumors, tumor, tumor genomic profiles, tumors
Author NameAffiliation
Robert SebraIcahn School of Medicine at Mount Sinai
Robert Sebra
Robert SebraIcahn School of Medicine at Mount Sinai
Robert Sebra
  • 1 - 4

Datasets

Release 1.2